Table 4.

Effect of physical exercise on metabolic parameters

	Control group		Experimental group
Variables	baseline	after intervention	baseline	after intervention
Uric acid, mg/dl	6.39 ± 0.21	6.56 ± 0.34	5.93 ± 0.28	6.09 ± 0.27
Hemoglobin, g/dl	15.65 ± 0.20	15.20 ± 0.26	15.63 ± 0.18	15.18 ± 0.24
Hematocrit, %	46.16 ± 0.57	46.99 ± 0.69	45.31 ± 0.65	44.11 ± 0.63
Platelets, 103/mm3	217.32 ± 15.70	211.52 ± 17.32	229.78 ± 12.42	218.91 ± 12.39
Bilirubin, mg/dl	0.90 ± 0.16	0.86 ± 0.12	1.17 ± 0.09	0.90 ± 0.08
Cholesterol, mg/dl	207.45 ± 5.70	199.00 ± 6.59	195.64 ± 7.89	173.23 ± 6.98*, #
HDL, mg/dl	53.59 ± 3.63	49.33 ± 3.36*	52.59 ± 3.42	58.50 ± 2.11*
LDL, mg/dl	127.18 ± 6.20	123.83 ± 6.89	118.16 ± 7.01	114.10 ± 5.96
VLDL, mg/dl	25.99 ± 2.13	24.62 ± 2.52	27.79 ± 3.44	28.56 ± 2.87
Creatinine, mg/dl	1.16 ± 0.04	1.10 ± 0	1.04 ± 0.05	0.75 ± 0.15
Alkaline phosphatase, U/l	102.69 ± 10.43	72.37 ± 8.38*	100.43 ± 16.91	71.17 ± 12.12*
GGT, U/l	45.35 ± 7.71	45.26 ± 7.38	43.73 ± 19.03	55.30 ± 17.19
SGOT, U/l	24.57 ± 1.86	22.78 ± 1.24	30.38 ± 3.53	29.13 ± 3.07
SGPT, U/l	27.79 ± 2.01	26.22 ± 2.27	31.77 ± 4.57	30.30 ± 2.76
Triglycerides, mg/dl	143.09 ± 17.44	138.52 ± 19.53	150.83 ± 20.08	107.78 ± 14.35*
Urea, mg/dl	35.58 ± 2.30	33.48 ± 1.69	29.15 ± 1.49	33.28 ± 1.49
Glucose, mg/dl	98.82 ± 2.55	93.81 ± 3.10	103.61 ± 3.26	93.30 ± 2.66*
T3, ng/dl	106.05 ± 6.14	97.51 ± 6.58	106.27 ± 3.74	91.48 ± 2.62*
T4, ng/dl	8.00 ± 0.39	7.38 ± 0.43*	8.08 ± 0.29	6.59 ± 0.22*
TSH, μIU/ml	3.73 ± 0.95	3.66 ± 0.87	2.53 ± 0.42	2.29 ± 0.25
PSA, ng/dl	1.97 ± 0.31	1.90 ± 0.32	2.20 ± 0.47	1.30 ± 0.23*

Data are presented as means ± SD. ANOVA for repeated measurement followed by the Duncan post hoc test.

^*p ≤ 0.05 vs. baseline intragroup condition

^#p ≤ 0.05 vs. postintervention intergroup condition. GGT = γ-Glutamyl transferase; SGPT = serum glutamic pyruvic transaminase; SGOT = serum glutamic oxaloacetic transaminase; TSH = thyroid-stimulating hormone.